racemetirosine has been researched along with Cardiac Cancer in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Biochemical studies confirmed its recurrence." | 1.29 | An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside. ( Acheson, LS; Anton, AH; Lina, AA; Sherman, BW, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anton, AH | 1 |
Sherman, BW | 1 |
Lina, AA | 1 |
Acheson, LS | 1 |
1 other study available for racemetirosine and Cardiac Cancer
Article | Year |
---|---|
An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Catecholamines; Drug Resistance; Echocardiography; Fe | 1993 |